EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Incorporation of Biologic Variables Into the Staging for Canine Cutaneous and Subcutaneous Mast Cell Tumours: Proposal of the UBo pTNM System

Laura Marconato iD, Eugenio Faroni iD, Emiliano Battisti, Riccardo Zaccone, Damiano Stefanello iD, Silvia Sabattini iD

Veterinary and Comparative Oncology · 2024

DOI: 10.1111/vco.13000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, 2024. Verfasst von Laura Marconato und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medical Sciences, University of Bologna, Ozzano dell'Emilia (Bologna), Italy. Hauptthemen laut MEDLINE: Dog Diseases, Neoplasm Staging, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Canine cutaneous mast cell tumours (MCTs) are currently staged based on the World Health Organization (WHO) classification, which has remained unchanged since its initial formulation. Our study aimed to assess the reliability of a novel pTNM staging system, which incorporates tumour extent (T), lymph node involvement (N), presence of distant metastases (M) and the two‐tier histologic grade. We analysed medical records of dogs with one or more cutaneous/subcutaneous completely staged MCT, undergoing tumour excision with lymphadenectomy, unless distant metastases were present, in which cases, medical therapy was administered. Dogs were categorized into three stages: I (T1‐2N0M0), II (T1‐2N1M0) and III (distant metastases). Stages I and II were further divided based on histologic grade into ‘low’ and ‘high’. Substage b was defined as the presence of tumour diameter of ≥3 cm and/or ulceration. Of 226 dogs, 87 (38.5%) were in Stage I (I‐low, n = 75; I‐high, n = 12), 107 (47.3%) in Stage II (II‐low, n = 59; II‐high, n = 48), and 32 (14.2%) in Stage III. The newly proposed staging system was able to significantly stratify the population for both time to progression and tumour‐specific survival. Compared to Stage I‐low, the risk of progression increased significantly for Stage I‐high (18.3 times), Stage II‐low (8.5 times), Stage II‐high (41.5 times) and Stage III (110.3 times). The staging system was highly prognostic for both cutaneous and subcutaneous MCTs. Prospective validation studies are essential to compare this new system with the current WHO staging and further validate its accuracy and clinical utility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesNeoplasm StagingSkin NeoplasmsAnimalsDogsFemaleMaleRetrospective Studies

Stichwörter der Autor:innen

dogsgradingmastocytomapTMNprognosisstagingsurvival

Autor:innen und Institutionen

  • Department of Veterinary Medical Sciences, University of Bologna, Ozzano dell'Emilia (Bologna), Italy.
  • Department of Veterinary Medicine and Animal Sciences, University of Milan, Lodi, Italy.

ORCID-Profile: Laura Marconato, Eugenio Faroni, Damiano Stefanello, Silvia Sabattini

Zitieren

APA

Marconato, L., Faroni, E., Battisti, E., Zaccone, R., Stefanello, D., & Sabattini, S. (2024). Incorporation of Biologic Variables Into the Staging for Canine Cutaneous and Subcutaneous Mast Cell Tumours: Proposal of the UBo pTNM System. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.13000

Vancouver

Marconato L, Faroni E, Battisti E, Zaccone R, Stefanello D, Sabattini S. Incorporation of Biologic Variables Into the Staging for Canine Cutaneous and Subcutaneous Mast Cell Tumours: Proposal of the UBo pTNM System. Veterinary and Comparative Oncology. 2024. doi:10.1111/vco.13000

BibTeX
@article{Marconato2024,
  author = {Marconato, Laura and Faroni, Eugenio and Battisti, Emiliano and Zaccone, Riccardo and Stefanello, Damiano and Sabattini, Silvia},
  title = {Incorporation of Biologic Variables Into the Staging for Canine Cutaneous and Subcutaneous Mast Cell Tumours: Proposal of the UBo pTNM System},
  journal = {Veterinary and Comparative Oncology},
  year = {2024},
  doi = {10.1111/vco.13000}
}
Kostenlos starten →